New Access Dashboard just dropped. Check out how your school is doing in terms of practicing equitable research and biomedical licensing. Link is in our Instagram bio!

*Required for all chapter leadership! Join UAEM North America for our annual All Chapters Call on October 5 from 9-10pm ET / 6-7pm PT. During this virtual event, you will hear updates from our chapter network and learn about North American campaigns Link is in our Instagram bio!

We are happy to announce our How to Grow Your Chapter training which is now live on our website! Our Empowerment team has prepared this new guide and training that will help you throughout every step of the way in starting a UAEM chapter at your university.

Remember the OMB provisions that put political appointees in charge of research grants, instead of qualified scientific peer researchers? Here's an update on this -- the fight for peer-reviewed research grants is not quite over.

Do you know what a pharmacy benefit manager is? They're owned by companies like UnitedHealthcare, CVS, and Cigna, and allow corporations to unfairly control your medications and maximize their profits. Lawmakers fighting back against these companies.

People living with sickle cell disease deserve research that reflects their experiences, represents them, and meets their needs. The UAEM Race & Health Equity Committee explores the structural inequities in sickle cell disease research and what needs to change, from a US lens.

Your birthday month, your coordinating committee activity!! Applications are open until August 9th in our Instagram bio!

At the UN's High Level Meeting on June 23-24, the US voted against the UN commitment to end the AIDS pandemic along with 7 other countries. Swipe to read more and learn why.

The European Union is currently negotiating its next research funding program. As the world's largest public funder for biomedical research and development, it is imperative that access is included in the bill. Swipe to learn more about this issue.

Public funding is the backbone of virtually all FDA-approved drugs. Without it, we would not have Lenacapavir, a novel HIV-prevention injection that has the potential to save millions of lives. Swipe through to read more about the impact of public funding and basic research.

Passionate about access to affordable medicine? UAEM is launching our new *** Inclusive Innovation Committee! We are seeking new, hard-working members looking to make a difference. If this sounds like you, scan the QR code in the post, or check out the link in our Instagram bio!

Trump's funding cuts on global health have worldwide consequences, putting everybody in danger. Read more to learn about its effects and the current Ebola outbreak in Western Africa. . . . . . . . . #health #accesstomedicines #policy #news #medicine

One of our members stands up to state UAEM's support for SB 895, the California Science and Health Research Bond Act. Swipe through to read more about this bill and what it implies for future research and pharmaceuticals in California.

Doctors without Borders is calling upon Gilead to cap the price at $40 for all low- and middle-income countries ASAP. Make your voice heard by joining their campaign at the link in our bio now. #publichealth #lenacapavir #accesstomedicines #healthcare #essentialmedicines

In case you missed out on last Friday night (as in 4/3), here are some flicks of UAEM's Friday night kickoff for the 2026 conference: People Before Profit: Advancing an Equitable Healthcare Future. There was incredible food, fun activities, an alumni panel, and amazing convos!

The biggest event of our conference: Global Access to Lenacapavir featuring Wesley Sundquist, PhD, University of Utah; Saba Sadat, PA-C, AIDS Healthcare Foundation; and Peter Maybarduk, JD, Public Citizen. You may attend this event without attending the entire conference.

Introducing our conference workshops!! If any of these interest you, there is still time to register for our conference People Before Profit: Advancing an Equitable Healthcare Future and get involved in healthcare advocacy!

Since the release of the new HIV prevention drug, lenacapavir, activists have been fighting to increase its availability to those who need it. Read to learn more about accessibility of HIV prevention.

Last chance to present at our North American Conference -- submit your abstracts by tomorrow 11:59PM! If you have any questions, feel free to reach out to our Instagram DM.

TLDR; We sent out a survey to universities' technology transfer groups to gauge their commitment to equitable and accessible research practices. Send an email urging them to fill it out so that we can hold them accountable! SEE LINK IN BIO FOR A PRE-WRITTEN EMAIL.